Active, not recruiting
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
NCT06799000
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
- Locations
-
- Medical Dermatology Specialists Phoenix, Arizona, United States
- Johnson Dermatology Fort Smith, Arkansas, United States
- Arkansas Research Trials North Little Rock, Arkansas, United States
- Cheryl Effron MD Inc Anaheim, California, United States